KCM
EPIX

Kennedy Capital Management’s ESSA Pharma EPIX Stock Holding History

Kennedy Capital Management’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-41,092
Closed -$249K – 695
2024
Q3 		$249K Buy
41,092
+6,627
+19% +$36.4K 0.01% 667
2024
Q2 		$181K Buy
+34,465
New +$219K ﹤0.01% 682

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Kennedy Capital Management's EPIX Position: Q4 2024 in Review

Kennedy Capital Management sold out of ESSA Pharma (EPIX) in Q4 2024, closing a stake of 41,092 shares — an estimated $249K sold.

Kennedy Capital Management first reported a position in EPIX in Q2 2024 and held it in 2 quarters. The position peaked at $249K in Q3 2024. 46 funds tracked by Wall St. Rank hold EPIX as of Q4 2024.

  • Kennedy Capital Management reported no remaining ESSA Pharma position as of Q4 2024 after selling out during the quarter.
  • Kennedy Capital Management sold 41,092 ESSA Pharma shares in Q4 2024, an estimated $249K.
  • Kennedy Capital Management first reported a position in ESSA Pharma in Q2 2024 and held it in 2 quarters.
  • Kennedy Capital Management's ESSA Pharma position peaked at $249K in Q3 2024.
  • 46 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2024.

Based on Kennedy Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.